The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Viking Therapeutics stock tumbled after the drugmaker released study results of its experimental weight-loss pill.

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

Ozempic accidentally became a cultural phenomenon. The drug, first delivered to diabetes patients in 2017, had a huge impact ...

VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in terms of body weight loss.

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to "align with federal coverage requirements." ...

Weight-loss wonder jabs such as Mounjaro are helping to transform the lives and health of millions, but one in five users ...

America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.

With the price of Mounjaro set to rise, many are hoping for a replacement and a new drug could be out next year ...

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Why are companies working so hard to make oral tablet forms of diabetes and weight loss drugs that target the glucagon-like ...